Volume : 11, Issue : 11, November – 2024
Title:
FORMULATION AND INVITRO EVALUATION OF PULSINCAP TECHNOLOGY OF INDOMETHACIN
Authors :
K. Hamsa Lekha, Aukunuru Jithan
Abstract :
The purpose of the present study was to design and evaluate an Oral, site specific, Pulsatile drug delivery system containing Indomethacin as a model drug, which can be time dependent manner, to modulate the drug level in synchrony is a member of the drug class known as statins It is used for lowering cholesterol based on Chronopharmaceutical considerations.
The basic design consists of an insoluble hard gelatin capsule body, filled with powder blend and sealed with a hydrogel plug. The powder blend containing Indomethacin, ludiflash, lycoat, SSG, MCC and talc was prepared and evaluated for flow properties and FTIR studies. From the obtained results, F12 powder blend formulation was selected for further fabrication of pulsatile capsules. Hydrogel plug was formulated in a lone and in combination of hydrophobic polymer like ethyl cellulose with hydrophilic polymers like HPMC K15M in 1:1, 1:2, and 2:1 ratio to maintain a suitable lag period and it was found that the drug release was controlled by the proportion of polymers used.
The prepared formulations were evaluated for drug content, weight variation and Invitro release studies. FTIR studies confirmed that there was no interaction between drug and polymers and Invitro release studies of pulsatile device revealed that increasing hydrophillic polymer content resulted in delayed release of Indomethacin from the pulsincap after a predetermined lag time of 6hrs. Based on invitro studies performed, P5F12 was found to be optimized formulation.
Key words: Pulsatile system; time dependent delivery; Indomethacin; Chronopharmaceutics; Invitro release studies
Cite This Article:
Please cite this article in press K. Hamsa Lekha et al., Formulation And Invitro Evaluation Of Pulsincap Technology Of Indomethacin.,Indo Am. J. P. Sci, 2024; 11 (11).
Number of Downloads : 10
References:
1. Sharagil L, Pony S. applied Bio-pharmaceutics and Pharmacokinetics. 5th ed. Singapur ; 2005: p. 481-2.
2. Robert W, Thomas P. Drug therapy for hypercholestemia and Dyslipidemia.In: Goodmen and Gilmans. The pharmacological basis of therapeutics. 10th ed. 2003: McGraw- hill. Medical publishing division p. 971-972.
3. Filippatos TD, Derdemezis CS, Elisaf MS. Department of Internal Medicine, School of Medicine, University of Loannina Greece. Available from: articles\Diet for hyperlipidemia.mht.
4. Scott MG. Atherogenic dyslipidemia associated with metabolic syndrome and Insulin resistance. vol 8. Suppl 1.
5. Bi-Botti CY. Chronopharmaceutics: Gimmick or clinically relevant approach to drug delivery- A Review. J Control Rel. 2004 Aug; 98(3):337-353.
6. Jain NK. Controlled and novel drug delivery. 1 st Ed. New Delhi: CBS Publishers; 2002.
7. Bussemer T, Otto I, Bodmeier R. Pulsatile drug delivery systems. Crit Rev Ther Drug Carrier Syst. 2001;18(5):433-58. Review.
8. Gothaskar AV, Joshi AM, Joshi NH. Pulsatile drug delivery system-A review. Drug Del Tech. 2004 June; 4(5).
9. Anal AK. Time-Controlled Pulsatile Delivery Systems for Bioactive Compounds. Recent Patents on Drug Delivery & Formulation. 2006 Dec; 1:73-79.
10. https://www.drugbank.ca/drugs/DB00175
11. Mustafa C, Mustafa SK, “UV spectroscopic method for determination of the Dissolution profile of Rivaroxaban “ 2014, doi:10.14227/DT210414, P56-59.
12. Kaur L and Kumar S. “Solid Dispersions: A Promising Approach for Improving Dissolution Characteristics of a poorly soluble drug.” Int. J. Pharma. Res. 2011, 3 (1),1-7.
13. Ludescher J. Crystalline form of rivaroxaban dehydrate. European Patents EP 2590970 A1, 2011.
14. Savjini KT, Gajjar AK, and Savjini JK. “ Drug solubility: Importance and Enhancement techniques”. Int. Sch. Res.Net. 2012, doi:10.5402/2012/195727.
15. Halsas M, Ervasti P, Veski P, Jürjenson H, Marvola M. Biopharmaceutical evaluation of timecontrolled press‐coated tablets containing polymers to adjust drug release. Eur J Drug Metabol Pharmacokinet., 1998;23: 190‐196
16. .Kro gel, Bodmeier R. Pulsatile drug release from an insoluble capsule body controlled by an erodible plug, Pharm. Res.,1998;15 (3): 474-481.
17. Sandeep M, Sai Kishore V, Sudheer B, Ershad S, Adithya K, Phanil kumar DS, Design and development of chronopharmaceutical drug delivery of lansoprazole Asian Journal of Pharmaceutical Research and Development ,2013; 1(5):1-9.
18. Ramesh B , Saikishore V, Lakshmana Rao R. Design And Development Of Pulsincap For Chronopharmaceutical Drug Delivery Losartan Potassium . Asian Journal of Pharmaceutical Research and Development. 2014,, 2(3) ,78-86.
19. Dasharath M Patel, Rushiraj H Jani,Chhagan N Patel. Design and evaluation of colon targeted modified pulsincap delivery of 5-fluorouracil according to circadian rhythm, Int J Pharm Investig ,2011; 1(3):172– 181.